Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
INDUSTRY
×
talimogene laherparepvec
×
Clear all
Filters
3
NCT02509507
2024-08-06
MASTERKEY-318
Amgen
Phase 1/2
Completed
127 enrolled
37 charts